Retinal Investigation Using Optos OCT Device
- Sponsor
- Optos, PLC
- Study ID
- NCT06846151
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- AMD - Age-Related Macular Degeneration
- Control Patients
- Diabetic Retinopathy
- Retinitis Pigmentosa (RP)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- retinal functional imaging — DEVICEthis is a proof of concept study
Study Details
Retinal investigation using OCT with control and diseased eyes
Key Dates
- First listed
- Feb 25, 2025
- Start date
- May 31, 2025
- Status verified
- Feb 2025
- Primary completion
- Nov 30, 2025
- Completion
- Jan 31, 2026
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: standard imaging processAll participants will undergo the same imaging
Primary Outcome Measure
OCT physical response data [ Time Frame: 6 months from recruitment start ]
Find similar trials
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic RetinopathyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama